Flavio Vincenti, MD
Professor
Medicine
School of Medicine

I have been at UCSF since 1975 and on the faculty of the Department of Medicine in the division of Nephrology since 1976 and have been involved with the transplant service in patient care and clinical trials with novel immunosuppression drugs

Education & Training

Show all (1) Hide

• Residency School of Medicine University of California, San Francisco

Websites

Show all (1) Hide

• Clinical Profile at UCSF Medical Center (ucsfhealth.org)

Grants and Projects

Show all (2) Hide

• Applying precision MEdicine to optimize desensitization with noveL bIOlogics or cellular theRApies in highly sensiTized kidney transplant patiEnts (AMELIORATE), NIH, 2014-2024
• General Clinical Research Center, NIH, 1974-2009

Publications (276)

Top publication keywords:
Graft SurvivalCyclosporineTacrolimusCalcineurin InhibitorsImmunoconjugatesKidney Failure, ChronicMycophenolic AcidReceptors, Interleukin-2Kidney TransplantationGraft RejectionBK VirusAbataceptImmunosuppressive AgentsGlomerulosclerosis, Focal SegmentalEverolimus

• The hepatocyte growth factor mimetic, ANG-3777, in kidney transplant recipients with delayed graft function: Results from a randomized phase 3 trial.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2024 Vincenti F, Bromberg J, Kim J, Faravardeh A, Leca N, Alperovich G, Csomor PA, Aslam S, Neylan J
• Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant.
  Journal of the American Society of Nephrology : JASN 2023 Vincenti F, Bestard O, Brar A, Cruzado JM, Seron D, Gaber AO, Ali N, Tambur AR, Lee H, Abbadessa G, Paul JA, Dudek M, Siegel RJ, Torija A, Semiond D, Lépine L, Ternes N, Montgomery RA, Stegall M
• State of the art in childhood nephrotic syndrome: concrete discoveries and unmet needs.
  Frontiers in immunology 2023 Vincenti F, Angeletti A, Ghiggeri GM
• Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial.
  JAMA 2023 Limaye AP, Budde K, Humar A, Vincenti F, Kuypers DRJ, Carroll RP, Stauffer N, Murata Y, Strizki JM, Teal VL, Gilbert CL, Haber BA
• Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses.
  Cell reports 2023 Duan M, Nguyen DC, Joyner CJ, Saney CL, Tipton CM, Andrews J, Lonial S, Kim C, Hentenaar I, Kosters A, Ghosn E, Jackson A, Knechtle S, Maruthamuthu S, Chandran S, Martin T, Rajalingam R, Vincenti F, …

Show all (271 more) Hide

• Open letter to Bristol Myers Squibb: Belatacept; we aren't done yet.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2023 Vincenti F, Budde K, Grinyo J, Rostaing L, Kirk AD, Larsen CP
• Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation study.
  BMJ (Clinical research ed.) 2023 Raynaud M, Al-Awadhi S, Juric I, Divard G, Lombardi Y, Basic-Jukic N, Aubert O, Dubourg L, Masson I, Mariat C, Prié D, Pernin V, Le Quintrec M, Larson TS, Stegall MD, Bikbov B, Ruggenenti P, Mesnard L…
• Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factors.
  Annals of translational medicine 2023 Rashmi P, Sigdel TK, Rychkov D, Damm I, Da Silva AA, Vincenti F, Lourenco AL, Craik CS, Reiser J, Sarwal MM
• Human Bone Marrow Plasma Cell Atlas: Maturation and Survival Pathways Unraveled by Single Cell Analyses.
  bioRxiv : the preprint server for biology 2023 Duan M, Nguyen DC, Joyner CJ, Saney CL, Tipton CM, Andrews J, Lonial S, Kim C, Hentenaar I, Kosters A, Ghosn E, Jackson A, Knechtle S, Maruthamuthu S, Chandran S, Martin T, Rajalingam R, Vincenti F, …
• Burden of neutropenia and leukopenia among adult kidney transplant recipients: A systematic literature review of observational studies.
  Transplant infectious disease : an official journal of the Transplantation Society 2023 Raval AD, Kistler KD, Tang Y, Vincenti F
• Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease Patients.
  Transplantation direct 2023 Looney CM, Schroeder A, Tavares E, Garg J, Schindler T, Vincenti F, Redfield RR, Jordan SC, Busque S, Woodle ES, Khan J, Eastham J, Micallef S, Austin CD, Morimoto A
• Infliximab Induction Lacks Efficacy and Increases BK Virus Infection in Deceased Donor Kidney Transplant Recipients: Results of the CTOT-19 Trial.
  Journal of the American Society of Nephrology : JASN 2022 Hricik DE, Armstrong B, Alhamad T, Brennan DC, Bromberg JS, Bunnapradist S, Chandran S, Fairchild RL, Foley DP, Formica R, Gibson IW, Kesler K, Kim SJ, Mannon RB, Menon MC, Newell KA, Nickerson P, …
• Outcomes among CMV-mismatched and highly sensitized kidney transplants recipients who develop neutropenia.
  Clinical transplantation 2022 Brar S, Berry R, Raval AD, Tang Y, Vincenti F, Skartsis N
• IL-6 and TNFα Drive Extensive Proliferation of Human Tregs Without Compromising Their Lineage Stability or Function.
  Frontiers in immunology 2021 Skartsis N, Peng Y, Ferreira LMR, Nguyen V, Ronin E, Muller YD, Vincenti F, Tang Q
• Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial.
  Journal of the American Society of Nephrology : JASN 2021 Budde K, Prashar R, Haller H, Rial MC, Kamar N, Agarwal A, de Fijter JW, Rostaing L, Berger SP, Djamali A, Leca N, Allamassey L, Gao S, Polinsky M, Vincenti F
• Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study.
  BMJ open 2021 Aubert O, Divard G, Pascual J, Oppenheimer F, Sommerer C, Citterio F, Tedesco H, Chadban S, Henry M, Vincenti F, Srinivas T, Watarai Y, Legendre C, Bernhardt P, Loupy A
• Tests for the noninvasive diagnosis of kidney transplant rejection should be evaluated by kidney transplant programs.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2021 Danovitch GM, Bunnapradist S, Cohen D, Hariharan S, McKay D, Ratner L, Stegall MD, Steiner RW, Stock PG, Vincenti F
• A Comparison of Ex Vivo Expanded Human Regulatory T Cells Using Allogeneic Stimulated B Cells or Monocyte-Derived Dendritic Cells.
  Frontiers in immunology 2021 Lee LM, Zhang H, Lee K, Liang H, Merleev A, Vincenti F, Maverakis E, Thomson AW, Tang Q
• Interleukin-6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: A randomized controlled trial.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2021 Chandran S, Leung J, Hu C, Laszik ZG, Tang Q, Vincenti FG
• Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation.
  Frontiers in genetics 2021 Zarinsefat A, Hartoularos G, Rychkov D, Rashmi P, Chandran S, Vincenti F, Yee CJ, Sarwal MM
• Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2020 Kirk AD, Adams AB, Durrbach A, Ford ML, Hildeman DA, Larsen CP, Vincenti F, Wojciechowski D, Woodle ES
• Phase 3 trial Design of the Hepatocyte Growth Factor Mimetic ANG-3777 in Renal Transplant Recipients With Delayed Graft Function.
  Kidney international reports 2020 Vincenti F, Kim J, Gouveia D, Pelle G, Mayne TJ, Neylan JF
• The impact of belatacept on the phenotypic heterogeneity of renal T cell-mediated alloimmune response: The critical role of maintenance treatment and inflammatory load.
  Clinical transplantation 2020 Dobi D, Vincenti F, Chandran S, Greenland JR, Bowman C, Chen A, Junger H, Laszik ZG
• Single-cell RNA sequencing of Tocilizumab-treated peripheral blood mononuclear cells as an in vitro model of inflammation.
  bioRxiv : the preprint server for biology 2020 Zarinsefat A, Hartoularos G, Chandran S, Yee CJ, Vincenti F, Sarwal MM
• A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection.
  Science translational medicine 2020 Yang JYC, Sarwal RD, Sigdel TK, Damm I, Rosenbaum B, Liberto JM, Chan-On C, Arreola-Guerra JM, Alberu J, Vincenti F, Sarwal MM
• Further Evidence That the Soluble Urokinase Plasminogen Activator Receptor Does Not Directly Injure Mice or Human Podocytes.
  Transplantation 2020 Harel E, Shoji J, Abraham V, Miller L, Laszik ZG, King A, Dobi D, Szabo G, Hann B, Sarwal MM, Craik CS, Vincenti F
• Assessment of 19 Genes and Validation of CRM Gene Panel for Quantitative Transcriptional Analysis of Molecular Rejection and Inflammation in Archival Kidney Transplant Biopsies.
  Frontiers in medicine 2019 Sigdel T, Nguyen M, Liberto J, Dobi D, Junger H, Vincenti F, Laszik Z, Sarwal MM
• A randomized, phase 1b study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of bleselumab, a fully human, anti-CD40 monoclonal antibody, in kidney transplantation.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2019 Vincenti F, Klintmalm G, Yang H, Ram Peddi V, Blahunka P, Conkle A, Santos V, Holman J
• Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients.
  Transplantation reviews (Orlando, Fla.) 2019 Pascual J, Berger SP, Chadban SJ, Citterio F, Kamar N, Hesselink DA, Legendre C, Eisenberger U, Oppenheimer F, Russ GR, Sommerer C, Rigotti P, Srinivas TR, Watarai Y, Henry ML, Vincenti F, Tedesco-…
• Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2019 Redfield RR, Jordan SC, Busque S, Vincenti F, Woodle ES, Desai N, Reed EF, Tremblay S, Zachary AA, Vo AA, Formica R, Schindler T, Tran H, Looney C, Jamois C, Green C, Morimoto A, Rajwanshi R, …
• Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2019 Berger SP, Sommerer C, Witzke O, Tedesco H, Chadban S, Mulgaonkar S, Qazi Y, de Fijter JW, Oppenheimer F, Cruzado JM, Watarai Y, Massari P, Legendre C, Citterio F, Henry M, Srinivas TR, Vincenti F, …
• Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing.
  Nature communications 2019 Pineda S, Sigdel TK, Liberto JM, Vincenti F, Sirota M, Sarwal MM
• Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantation.
  Clinical transplantation 2019 Harel E, Shoji J, Abraham V, Miller L, Laszik Z, Thurison T, King A, Olshen A, Leung J, Szabo G, Hann B, Høyer-Hansen G, Craik CS, Vincenti F
• Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial.
  Transplantation direct 2018 Busque S, Vincenti FG, Tedesco Silva H, O'Connell PJ, Yoshida A, Friedewald JJ, Steinberg SM, Budde K, Broeders EN, Kim YS, Hahn CM, Li H, Chan G
• Nuclear Factor of Activated T Cell-regulated Cytokine Gene Expression for Adjustment of Tacrolimus in Kidney Transplant Recipients: A Randomized Controlled Pilot Trial.
  Transplantation direct 2018 Webber AB, Tatapudi V, Maw TT, Peralta C, Leung JCY, Vincenti F
• A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2018 Vincenti F, Budde K, Merville P, Shihab F, Ram Peddi V, Shah M, Wyburn K, Cassuto-Viguier E, Weidemann A, Lee M, Flegel T, Erdman J, Wang X, Lademacher C
• Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
  Journal of the American Society of Nephrology : JASN 2018 Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt …
• Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients administered belatacept or cyclosporine in BENEFIT and BENEFIT-EXT.
  Clinical transplantation 2018 Florman S, Vincenti F, Durrbach A, Abouljoud M, Bresnahan B, Garcia VD, Mulloy L, Rice K, Rostaing L, Zayas C, Calderon K, Meier-Kriesche U, Polinsky M, Yang L, Medina Pestana J, Larsen CP
• Targeted Transcriptional Profiling of Kidney Transplant Biopsies.
  Kidney international reports 2018 Sigdel TK, Nguyen M, Dobi D, Hsieh SC, Liberto JM, Vincenti F, Sarwal MM, Laszik Z
• Mycophenolate Mofetil Withdrawal With Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients.
  Transplantation proceedings 2017 Wojciechowski D, Chandran S, Webber A, Hirose R, Vincenti F
• Ten-year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4-weekly or 8-weekly.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2017 Vincenti F, Blancho G, Durrbach A, Grannas G, Grinyó J, Meier-Kriesche HU, Polinsky M, Yang L, Larsen CP
• Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2017 Chandran S, Tang Q, Sarwal M, Laszik ZG, Putnam AL, Lee K, Leung J, Nguyen V, Sigdel T, Tavares EC, Yang JYC, Hellerstein M, Fitch M, Bluestone JA, Vincenti F
• Retrospective evaluation of the efficacy and safety of belatacept with thymoglobulin induction and maintenance everolimus: A single-center clinical experience.
  Clinical transplantation 2017 Wojciechowski D, Chandran S, Yang JYC, Sarwal MM, Vincenti F
• Transplant trials with Tregs: perils and promises.
  The Journal of clinical investigation 2017 Tang Q, Vincenti F
• B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2017 Asare A, Kanaparthi S, Lim N, Phippard D, Vincenti F, Friedewald J, Pavlakis M, Poggio E, Heeger P, Mannon R, Burrell BE, Morrison Y, Bridges N, Sanz I, Chandraker A, Newell KA, Turka LA
• A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis.
  Kidney international reports 2017 Vincenti F, Fervenza FC, Campbell KN, Diaz M, Gesualdo L, Nelson P, Praga M, Radhakrishnan J, Sellin L, Singh A, Thornley-Brown D, Veronese FV, Accomando B, Engstrand S, Ledbetter S, Lin J, Neylan J, …
• Belatacept: the challenges with transformational drugs.
  Translational andrology and urology 2017 Vincenti F
• Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients.
  Clinical transplantation 2017 Wojciechowski D, Chandran S, Vincenti F
• Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial.
  American journal of kidney diseases : the official journal of the National Kidney Foundation 2016 Grinyó JM, Del Carmen Rial M, Alberu J, Steinberg SM, Manfro RC, Nainan G, Vincenti F, Jones-Burton C, Kamar N
• Current status of costimulatory blockade in renal transplantation.
  Current opinion in nephrology and hypertension 2016 Wojciechowski D, Vincenti F
• Costimulatory Blockade and Use of mTOR Inhibitors: Avoiding Injury Part 2.
  Advances in chronic kidney disease 2016 Wojciechowski D, Vincenti F
• Steroid-Responsive Acute Rejection Should Not Be the End Point for Immunosuppressive Trials.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2016 Klintmalm GB, Vincenti F, Kirk A
• Belatacept and Long-Term Outcomes in Kidney Transplantation.
  The New England journal of medicine 2016 Vincenti F
• An Update on Calcineurin Inhibitor-Free Regimens: The Need Persists, but the Landscape has Changed.
  Transplantation 2016 Webber AB, Vincenti F
• Belatacept and Long-Term Outcomes in Kidney Transplantation.
  The New England journal of medicine 2016 Vincenti F, Rostaing L, Grinyo J, Rice K, Steinberg S, Gaite L, Moal MC, Mondragon-Ramirez GA, Kothari J, Polinsky MS, Meier-Kriesche HU, Munier S, Larsen CP
• A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation.
  Transplantation 2016 Wolf M, Weir MR, Kopyt N, Mannon RB, Von Visger J, Deng H, Yue S, Vincenti F
• A Computational Gene Expression Score for Predicting Immune Injury in Renal Allografts.
  PloS one 2015 Sigdel TK, Bestard O, Tran TQ, Hsieh SC, Roedder S, Damm I, Vincenti F, Sarwal MM
• Evaluation of the effect of tofacitinib exposure on outcomes in kidney transplant patients.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2015 Vincenti F, Silva HT, Busque S, O'Connell PJ, Russ G, Budde K, Yoshida A, Tortorici MA, Lamba M, Lawendy N, Wang W, Chan G
• The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study.
  PLoS medicine 2014 Roedder S, Sigdel T, Salomonis N, Hsieh S, Dai H, Bestard O, Metes D, Zeevi A, Zeevi A, Gritsch A, Cheeseman J, Macedo C, Peddy R, Medeiros M, Vincenti F, Asher N, Salvatierra O, Shapiro R, Kirk A, …
• Role of podocyte B7-1 in diabetic nephropathy.
  Journal of the American Society of Nephrology : JASN 2014 Fiorina P, Vergani A, Bassi R, Niewczas MA, Altintas MM, Pezzolesi MG, D'Addio F, Chin M, Tezza S, Ben Nasr M, Mattinzoli D, Ikehata M, Corradi D, Schumacher V, Buvall L, Yu CC, Chang JM, La Rosa S, …
• Clinical aspects: focusing on key unique organ-specific issues of renal transplantation.
  Cold Spring Harbor perspectives in medicine 2014 Chandran S, Vincenti F
• Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2013 Rostaing L, Vincenti F, Grinyó J, Rice KM, Bresnahan B, Steinberg S, Gang S, Gaite LE, Moal MC, Mondragón-Ramirez GA, Kothari J, Pupim L, Larsen CP
• Tofacitinib in kidney transplantation.
  Expert opinion on investigational drugs 2013 Wojciechowski D, Vincenti F
• Report of the second joint meeting of ESOT and AST: current pipelines in biotech and pharma.
  Transplant international : official journal of the European Society for Organ Transplantation 2013 van Gelder T, Baan C, Vincenti F, Mannon RB
• Native renal function after combined liver-kidney transplant for type 1 hepatorenal syndrome: initial report on the use of postoperative Technetium-99 m-mercaptoacetyltriglycine scans.
  Transplant international : official journal of the European Society for Organ Transplantation 2013 Vagefi PA, Qian JJ, Carlson DM, Aparici CM, Hirose R, Vincenti F, Wojciechowski D
• Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year.
  Transplantation 2012 Wojciechowski D, Chanda R, Chandran S, Lee B, Webber A, Macaraig M, Tomlanovich S, Vincenti F
• Belatacept in kidney transplantation.
  Current opinion in organ transplantation 2012 Wojciechowski D, Vincenti F
• Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2012 Hirsch HH, Vincenti F, Friman S, Tuncer M, Citterio F, Wiecek A, Scheuermann EH, Klinger M, Russ G, Pescovitz MD, Prestele H
• Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update.
  Biologics : targets & therapy 2012 Wojciechowski D, Vincenti F
• Altered balance between effector T cells and FOXP3+ HELIOS+ regulatory T cells after thymoglobulin induction in kidney transplant recipients.
  Transplant international : official journal of the European Society for Organ Transplantation 2012 Tang Q, Leung J, Melli K, Lay K, Chuu EL, Liu W, Bluestone JA, Kang SM, Peddi VR, Vincenti F
• Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study.
  Transplant international : official journal of the European Society for Organ Transplantation 2012 Grinyo J, Alberu J, Contieri FL, Manfro RC, Mondragon G, Nainan G, Rial Mdel C, Steinberg S, Vincenti F, Dong Y, Thomas D, Kamar N
• Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2012 Vincenti F, Tedesco Silva H, Busque S, O'Connell P, Friedewald J, Cibrik D, Budde K, Yoshida A, Cohney S, Weimar W, Kim YS, Lawendy N, Lan SP, Kudlacz E, Krishnaswami S, Chan G
• Are calcineurin inhibitors-free regimens ready for prime time?
  Kidney international 2012 Vincenti F
• Beyond belatacept: praise and progress for the FDA.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2012 Vincenti F
• Targeting JAK3 in kidney transplantation: current status and future options.
  Current opinion in organ transplantation 2011 Wojciechowski D, Vincenti F
• C4d/CD34 double-immunofluorescence staining of renal allograft biopsies for assessing peritubular capillary C4d positivity.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011 Jen KY, Nguyen TB, Vincenti FG, Laszik ZG
• Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2011 Vincenti F, Larsen CP, Alberu J, Bresnahan B, Garcia VD, Kothari J, Lang P, Urrea EM, Massari P, Mondragon-Ramirez G, Reyes-Acevedo R, Rice K, Rostaing L, Steinberg S, Xing J, Agarwal M, Harler MB, …
• Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetes.
  Clinical journal of the American Society of Nephrology : CJASN 2011 Rostaing L, Neumayer HH, Reyes-Acevedo R, Bresnahan B, Florman S, Vitko S, Heifets M, Xing J, Thomas D, Vincenti F
• Belatacept.
  Nature reviews. Drug discovery 2011 Vincenti F, Dritselis A, Kirkpatrick P
• Challenges and opportunities in targeting the costimulation pathway in solid organ transplantation.
  Seminars in immunology 2011 Wojciechowski D, Vincenti F
• Novel strategies in immunosuppression: issues in perspective.
  Transplantation 2011 Webber A, Hirose R, Vincenti F
• Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies).
  Transplantation 2011 Vanrenterghem Y, Bresnahan B, Campistol J, Durrbach A, Grinyó J, Neumayer HH, Lang P, Larsen CP, Mancilla-Urrea E, Pestana JM, Block A, Duan T, Glicklich A, Gujrathi S, Vincenti F
• Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2011 Friman S, Arns W, Nashan B, Vincenti F, Banas B, Budde K, Cibrik D, Chan L, Klempnauer J, Mulgaonkar S, Nicholson M, Wahlberg J, Wissing KM, Abrams K, Witte S, Woodle ES
• A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.
  Kidney international 2011 Trachtman H, Fervenza FC, Gipson DS, Heering P, Jayne DR, Peters H, Rota S, Remuzzi G, Rump LC, Sellin LK, Heaton JP, Streisand JB, Hard ML, Ledbetter SR, Vincenti F
• Response to questions regarding the design and results of the IMPACT trial.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2011 Humar A, IMPACT Investigators Steering Committee, Peeters P, Abramowicz D, Humar A, Lebranchu Y, Hauser I, Jardine A, Limaye AP, Vincenti F, Punch JD, Blumberg E
• An integrated safety profile analysis of belatacept in kidney transplant recipients.
  Transplantation 2010 Grinyó J, Charpentier B, Pestana JM, Vanrenterghem Y, Vincenti F, Reyes-Acevedo R, Apanovitch AM, Gujrathi S, Agarwal M, Thomas D, Larsen CP
• Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies.
  Transplantation 2010 Larsen CP, Grinyó J, Medina-Pestana J, Vanrenterghem Y, Vincenti F, Breshahan B, Campistol JM, Florman S, Rial Mdel C, Kamar N, Block A, Di Russo G, Lin CS, Garg P, Charpentier B
• Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study.
  Transplantation 2010 Humar A, Limaye AP, Blumberg EA, Hauser IA, Vincenti F, Jardine AG, Abramowicz D, Ives JA, Farhan M, Peeters P
• Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade.
  Transplantation 2010 Posselt AM, Szot GL, Frassetto LA, Masharani U, Tavakol M, Amin R, McElroy J, Ramos MD, Kerlan RK, Fong L, Vincenti F, Bluestone JA, Stock PG
• How the development of new biological agents may help minimize immunosuppression in kidney transplantation: the impact of belatacept.
  Current opinion in organ transplantation 2010 Wojciechowski D, Vincenti F
• Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010 Ferguson R, Grinyó J, Vincenti F, Kaufman DB, Woodle ES, Marder BA, Citterio F, Marks WH, Agarwal M, Wu D, Dong Y, Garg P
• Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study.
  Clinical journal of the American Society of Nephrology : CJASN 2010 Rostaing L, Massari P, Garcia VD, Mancilla-Urrea E, Nainan G, del Carmen Rial M, Steinberg S, Vincenti F, Shi R, Di Russo G, Thomas D, Grinyó J
• Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database.
  American journal of kidney diseases : the official journal of the National Kidney Foundation 2010 Kuo HT, Sampaio MS, Vincenti F, Bunnapradist S
• Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010 Posselt AM, Bellin MD, Tavakol M, Szot GL, Frassetto LA, Masharani U, Kerlan RK, Fong L, Vincenti FG, Hering BJ, Bluestone JA, Stock PG
• Five-year safety and efficacy of belatacept in renal transplantation.
  Journal of the American Society of Nephrology : JASN 2010 Vincenti F, Blancho G, Durrbach A, Friend P, Grinyo J, Halloran PF, Klempnauer J, Lang P, Larsen CP, Mühlbacher F, Nashan B, Soulillou JP, Vanrenterghem Y, Wekerle T, Agarwal M, Gujrathi S, Shen J, …
• The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010 Humar A, Lebranchu Y, Vincenti F, Blumberg EA, Punch JD, Limaye AP, Abramowicz D, Jardine AG, Voulgari AT, Ives J, Hauser IA, Peeters P
• A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study).
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010 Durrbach A, Pestana JM, Pearson T, Vincenti F, Garcia VD, Campistol J, Rial Mdel C, Florman S, Block A, Di Russo G, Xing J, Garg P, Grinyó J
• A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010 Vincenti F, Charpentier B, Vanrenterghem Y, Rostaing L, Bresnahan B, Darji P, Massari P, Mondragon-Ramirez GA, Agarwal M, Di Russo G, Lin CS, Garg P, Larsen CP
• Kidney transplantation at UCSF: 8,300 transplants and onward.
  Clinical transplants 2010 Wojciechowski D, Hirose R, Stock P, Vincenti F, Baxter-Lowe LA, Salvatierra O
• Novel B cell therapeutic targets in transplantation and immune-mediated glomerular diseases.
  Clinical journal of the American Society of Nephrology : CJASN 2009 Vincenti F, Cohen SD, Appel G
• KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary.
  Kidney international 2009 Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, Green MD, Jha V, Josephson MA, Kiberd BA, Kreis HA, McDonald RA, Newmann JM, Obrador GT, Vincenti FG, Cheung M, Earley A, Raman G, …
• Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009 Busque S, Leventhal J, Brennan DC, Steinberg S, Klintmalm G, Shah T, Mulgaonkar S, Bromberg JS, Vincenti F, Hariharan S, Slakey D, Peddi VR, Fisher RA, Lawendy N, Wang C, Chan G
• Kidney transplantation: the ideal immunosuppression regimen.
  Advances in chronic kidney disease 2009 Yabu JM, Vincenti F
• Transplantation: To convert or not to convert: lessons from the CONVERT trial.
  Nature reviews. Nephrology 2009 Bunnapradist S, Vincenti F
• The AST's perspective on the proposed kidney allocation system.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009 Murphy B, Vincenti F, Meier-Kriesche HU
• The challenge of achieving target drug concentrations in clinical trials: experience from the Symphony study.
  Transplantation 2009 Ekberg H, Mamelok RD, Pearson TC, Vincenti F, Tedesco-Silva H, Daloze P
• Long-term renal function and cardiovascular disease risk in obese kidney donors.
  Clinical journal of the American Society of Nephrology : CJASN 2009 Tavakol MM, Vincenti FG, Assadi H, Frederick MJ, Tomlanovich SJ, Roberts JP, Posselt AM
• Evolving trends in induction therapy.
  Transplantation reviews (Orlando, Fla.) 2009 Arias M, Campistol JM, Vincenti F
• Assessment of belatacept-mediated costimulation blockade through evaluation of CD80/86-receptor saturation.
  Transplantation 2009 Latek R, Fleener C, Lamian V, Kulbokas E, Davis PM, Suchard SJ, Curran M, Vincenti F, Townsend R
• Mycophenolic acid exposure after administration of mycophenolate mofetil in the presence and absence of cyclosporin in renal transplant recipients.
  Clinical pharmacokinetics 2009 Kuypers DR, Ekberg H, Grinyó J, Nashan B, Vincenti F, Snell P, Mamelok RD, Bouw RM
• The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008 Bluestone JA, Liu W, Yabu JM, Laszik ZG, Putnam A, Belingheri M, Gross DM, Townsend RM, Vincenti F
• What's next in the pipeline.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008 Vincenti F, Kirk AD
• Tolerance versus immunosuppression: a perspective.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008 Halloran PF, Bromberg J, Kaplan B, Vincenti F
• Association of four DNA polymorphisms with acute rejection after kidney transplantation.
  Transplant international : official journal of the European Society for Organ Transplantation 2008 Grinyó J, Vanrenterghem Y, Nashan B, Vincenti F, Ekberg H, Lindpaintner K, Rashford M, Nasmyth-Miller C, Voulgari A, Spleiss O, Truman M, Essioux L
• Open letter to the FDA: new drug trials must be relevant.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008 Vincenti F, Klintmalm G, Halloran PF
• A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008 Vincenti F, Schena FP, Paraskevas S, Hauser IA, Walker RG, Grinyo J, FREEDOM Study Group
• Costimulation blockade in autoimmunity and transplantation.
  The Journal of allergy and clinical immunology 2008 Vincenti F
• Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: The CAESAR Study. Am J Transplant 7, 560-570, 2007.
  Clinical journal of the American Society of Nephrology : CJASN 2008 Ekberg H, Grinyo J, Nashan B, Vanrenterghem Y, Vincenti F, Voulgari A, Truman M, Nasmyth-Miller C, Rashford M, CAESAR study group
• Proteomics of plasma and urine in primary nephrotic syndrome in children.
  Contributions to nephrology 2008 Candiano G, Musante L, Petretto A, Bruschi M, Santucci L, Urbani A, Scolari F, Gusmano R, Carraro M, Zennaro C, Vincenti F, Ghiggeri GM
• Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 7 1506-1514, 2007.
  Clinical journal of the American Society of Nephrology : CJASN 2008 Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Viecek A, Chadban S, El-Shahawy M, Budde K, Goto N, DIRECT (…
• Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007 Yabu JM, Ho B, Scandling JD, Vincenti F
• A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007 Vincenti F, Mendez R, Pescovitz M, Rajagopalan PR, Wilkinson AH, Butt K, Laskow D, Slakey DP, Lorber MI, Garg JP, Garovoy M
• Novel immunosuppression: small molecules and biologics.
  Seminars in nephrology 2007 Yabu JM, Vincenti F
• Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients.
  British journal of clinical pharmacology 2007 Pescovitz MD, Vincenti F, Hart M, Melton L, Whelchel J, Mulgaonkar S, McKay D, Leung M, Calleja E, Bouw MR
• Costimulation blockade--what will the future bring?
  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007 Vincenti F
• Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007 Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Wiecek A, Chadban S, El-Shahawy M, Budde K, Goto N, DIRECT (…
• Sirolimus: defining nephrotoxicity in the renal transplant recipient.
  Clinical journal of the American Society of Nephrology : CJASN 2007 Tomlanovich SJ, Vincenti F
• Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin.
  Journal of the American Society of Nephrology : JASN 2007 Musante L, Candiano G, Petretto A, Bruschi M, Dimasi N, Caridi G, Pavone B, Del Boccio P, Galliano M, Urbani A, Scolari F, Vincenti F, Ghiggeri GM
• Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007 Ekberg H, Grinyó J, Nashan B, Vanrenterghem Y, Vincenti F, Voulgari A, Truman M, Nasmyth-Miller C, Rashford M
• T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation.
  Annual review of medicine 2007 Vincenti F, Luggen M
• Therapeutic drug monitoring of mycophenolic acid in solid organ transplant patients treated with mycophenolate mofetil: review of the literature.
  Transplantation 2006 Arns W, Cibrik DM, Walker RG, Mourad G, Budde K, Mueller EA, Vincenti F
• Living donor kidney transplant recipients and clinical trials: participation profiles and impact on post-transplant care.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2006 Brennan TV, Fuller TF, Vincenti F, Chan S, Chang CK, Bostrom A, Zlatunich JK, Tomlanovich SJ, Feng S
• Immunosuppression: today, tomorrow, and withdrawal.
  Seminars in liver disease 2006 Hirose R, Vincenti F
• Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients.
  Transplant international : official journal of the European Society for Organ Transplantation 2006 Vincenti F, de Andrés A, Becker T, Choukroun G, Cole E, González-Posada JM, Kumar MA, Moore R, Nadalin S, Nashan B, Rostaing L, Saito K, Yoshimura N
• Antibodies come back to the forefront in transplantation.
  Clinical journal of the American Society of Nephrology : CJASN 2006 Vincenti F
• A multicenter, prospective study of C2-monitored cyclosporine microemulsion in a U.S. population of de novo renal transplant recipients.
  Transplantation 2005 Vincenti F, Mendez R, Curtis J, Light J, Pearson T, Wu YM, Katz SM, Akalin E, Esterl R, Gugliuzza K, Shihab F, Jordan S, Jonsson J, Molmenti E, Barbeito R
• Toxicity-sparing protocols using mycophenolate mofetil in renal transplantation.
  Transplantation 2005 Land W, Vincenti F
• Current use and future trends in induction therapy.
  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2005 Vincenti F
• Rapidly developing nephrocalcinosis in a patient with end-stage liver disease who received a domino liver transplant from a patient with known congenital oxalosis.
  Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2005 Aziz S, Callen PW, Vincenti F, Hirose R
• Costimulation blockade with belatacept in renal transplantation.
  The New England journal of medicine 2005 Vincenti F, Larsen C, Durrbach A, Wekerle T, Nashan B, Blancho G, Lang P, Grinyo J, Halloran PF, Solez K, Hagerty D, Levy E, Zhou W, Natarajan K, Charpentier B, Belatacept Study Group
• A drug of the past, a lesson for the future.
  Pediatric transplantation 2005 Vincenti F
• Guidelines for the treatment and management of new-onset diabetes after transplantation.
  Clinical transplantation 2005 Wilkinson A, Davidson J, Dotta F, Home PD, Keown P, Kiberd B, Jardine A, Levitt N, Marchetti P, Markell M, Naicker S, O'Connell P, Schnitzler M, Standl E, Torregosa JV, Uchida K, Valantine H, Villamil…
• New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005 Vincenti F, Ghiggeri GM
• Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation.
  Transplantation proceedings 2005 Vincenti F, Tuncer M, Castagneto M, Klinger M, Friman S, Scheuermann EH, Wiecek A, Russ GR, Martinek A, Nonnast-Daniel B, DIRECT Study Group
• An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency.
  Clinical transplantation 2005 Peddi VR, Jensik S, Pescovitz M, Pirsch J, Adler SH, Thistlethwaite JR, Vincenti F, Cohen DJ
• Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation.
  Contemporary clinical trials 2005 Vincenti F, Rostaing L, DIRECT (Diabetes Incidence after REnal Transplantation: Neoral C2 monitoring versus Tacrolimus) inve
• A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005 Woodle ES, Vincenti F, Lorber MI, Gritsch HA, Hricik D, Washburn K, Matas AJ, Gallichio M, Neylan J
• Chronic induction. What's new in the pipeline.
  Contributions to nephrology 2005 Vincenti F
• BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004 Lipshutz GS, Flechner SM, Govani MV, Vincenti F
• Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patients.
  Transplant international : official journal of the European Society for Organ Transplantation 2004 Vincenti F
• Infliximab in the treatment of steroid-dependent ulcerative colitis.
  European review for medical and pharmacological sciences 2004 Armuzzi A, De Pascalis B, Lupascu A, Fedeli P, Leo D, Mentella MC, Vincenti F, Melina D, Gasbarrini G, Pola P, Gasbarrini A
• A decade of progress in kidney transplantation.
  Transplantation 2004 Vincenti F
• Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy.
  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004 Ghiggeri GM, Carraro M, Vincenti F
• Optimizing the use of cyclosporine (Neoral) for recipients of living donor kidneys.
  Transplantation proceedings 2004 Vincenti F, Brennan TV, Fuller TF, Feng S
• Retransplantation in patients with graft loss caused by polyoma virus nephropathy.
  Transplantation 2004 Ramos E, Vincenti F, Lu WX, Shapiro R, Trofe J, Stratta RJ, Jonsson J, Randhawa PS, Drachenberg CB, Papadimitriou JC, Weir MR, Wali RK
• Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporine and steroids in renal transplantation.
  Clinical transplantation 2003 Pescovitz MD, Bumgardner G, Gaston RS, Kirkman RL, Light S, Patel IH, Nieforth K, Vincenti F
• CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
  Transplantation 2003 Posselt AM, Vincenti F, Bedolli M, Lantz M, Roberts JP, Hirose R
• Immunosuppression minimization: current and future trends in transplant immunosuppression.
  Journal of the American Society of Nephrology : JASN 2003 Vincenti F
• Prevalence and management of anemia in renal transplant recipients: a European survey.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003 Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, Kliem V, Legendre C, Morais Sarmento AL, Vincenti F
• De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco.
  Transplantation proceedings 2003 Vincenti F, Stock P
• Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003 Vincenti F, Monaco A, Grinyo J, Kinkhabwala M, Roza A
• New monoclonal antibodies in renal transplantation.
  Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2003 Vincenti F
• Pharmacokinetic and pharmacodynamic studies of one or two doses of daclizumab in renal transplantation.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003 Vincenti F, Pace D, Birnbaum J, Lantz M
• What's in the pipeline? New immunosuppressive drugs in transplantation.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2002 Vincenti F
• A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years.
  Transplantation 2002 Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch J
• Effect of calcineurin inhibitor therapy on P-gp expression and function in lymphocytes of renal transplant patients: a preliminary evaluation.
  Journal of clinical pharmacology 2002 Parasrampuria DA, Lantz MV, Birnbaum JL, Vincenti FG, Benet LZ
• Interleukin-2 receptor monoclonal antibodies in renal transplantation: current use and emerging regimens.
  Transplantation proceedings 2001 Vincenti F
• Daclizumab (humanized anti-IL2Ralpha mAb) prophylaxis for prevention of acute rejection in renal transplant recipients with delayed graft function.
  Transplantation 2001 Bumgardner GL, Ramos E, Lin A, Vincenti F, Daclizumab Triple Therapy and Double Therapy Groups
• Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation.
  Transplantation proceedings 2001 Vincenti F, Monaco A, Grinyo J, Kinkhabwala M, Neylan J, Roza A, Somberg K
• Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trial.
  Transplantation proceedings 2001 Vincenti F
• The role of newer monoclonal antibodies in renal transplantation.
  Transplantation proceedings 2001 Vincenti F
• Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors.
  Transplantation 2000 Norman DJ, Vincenti F, de Mattos AM, Barry JM, Levitt DJ, Wedel NI, Maia M, Light SE
• A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function.
  Clinical transplantation 2000 Chang GJ, Mahanty HD, Vincenti F, Freise CE, Roberts JP, Ascher NL, Stock PG, Hirose R
• Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: pharmacokinetics and tolerability.
  Journal of clinical pharmacology 2000 Pirsch J, Bekersky I, Vincenti F, Boswell G, Woodle ES, Alak A, Kruelle M, Fass N, Facklam D, Mekki Q
• The role of daclizumab in balancing resources for inpatient and outpatient transplant services.
  Progress in transplantation (Aliso Viejo, Calif.) 2000 Korsun A, Vincenti F, Ruck D, Whitelaw N, Ladoulis C, Whitelaw G
• Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis.
  Transplant international : official journal of the European Society for Organ Transplantation 2000 Ekberg H, Bäckman L, Tufveson G, Tydén G, Nashan B, Vincenti F
• Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR).
  Transplantation 1999 Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz CJ, Roza AM, Vincenti F, George V
• Daclizumab: novel biologic immunoprophylaxis for prevention of acute rejection in renal transplantation.
  Transplantation proceedings 1999 Vincenti F
• Potential of daclizumab in solid organ transplantation.
  BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 1999 Vincenti F
• Can antibody prophylaxis allow sparing of other immunosuppressives?
  Transplantation proceedings 1999 Vincenti F, Grinyo J, Ramos E, Nashan B, Stuart F, Kuypers D, Brattstrom C, Cho S, Ekberg H, Johnson R
• Recurrent and de novo glomerular disease after renal transplantation: a report from renal allograft disease registry.
  Transplantation proceedings 1999 Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz C, Roza AM, Vincenti F, George V
• Review of transplantation--1999.
  Clinical transplants 1999 Hirose R, Vincenti F
• Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group.
  Transplantation 1998 Solez K, Vincenti F, Filo RS
• Daclizumab: outcome of phase III trials and mechanism of action. Double Therapy and the Triple Therapy Study Groups.
  Transplantation proceedings 1998 Vincenti F, Nashan B, Light S
• Single-center long-term results of renal transplantation for IgA nephropathy.
  Transplantation 1998 Bumgardner GL, Amend WC, Ascher NL, Vincenti FG
• Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group.
  The New England journal of medicine 1998 Vincenti F, Kirkman R, Light S, Bumgardner G, Pescovitz M, Halloran P, Neylan J, Wilkinson A, Ekberg H, Gaston R, Backman L, Burdick J
• Selection strategies for successful utilization of less than 15.kg pediatric donor kidneys.
  Transplantation proceedings 1997 Bretan PN, Freise C, Goldstein R, Osorio R, Tomlanovich S, Amend W, Mathur V, Vincenti F
• A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
  Transplantation 1997 Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS
• FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group.
  Transplantation proceedings 1997 Miller J, Pirsch JD, Deierhoi M, Vincenti F, Filo RS
• Immunologic and patient selection strategies for successful utilization of less than 15 kg pediatric donor kidneys--long term experiences with 40 transplants.
  Transplantation 1997 Bretan PN, Friese C, Goldstein RB, Osorio RW, Tomlanovich S, Amend W, Mathur V, Vincenti F
• A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation.
  Transplantation 1997 Vincenti F, Lantz M, Birnbaum J, Garovoy M, Mould D, Hakimi J, Nieforth K, Light S
• An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group.
  Transplantation 1996 Laskow DA, Vincenti F, Neylan JF, Mendez R, Matas AJ
• A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.
  Transplantation 1996 Woodle ES, Thistlethwaite JR, Gordon JH, Laskow D, Deierhoi MH, Burdick J, Pirsch JD, Sollinger H, Vincenti F, Burrows L, Schwartz B, Danovitch GM, Wilkinson AH, Shaffer D, Simpson MA, Freeman RB, …
• One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group.
  Transplantation 1996 Vincenti F, Laskow DA, Neylan JF, Mendez R, Matas AJ
• Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.
  The New England journal of medicine 1996 Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F
• In vivo (phase I) trial and in vitro efficacy of humanized anti-Tac for the prevention of rejection in renal transplant recipients.
  Transplantation proceedings 1996 Stock PG, Lantz M, Light S, Vincenti F
• Pentoxifylline does not prevent the cytokine-induced first dose reaction following OKT3--a randomized, double-blind placebo-controlled study.
  Transplantation 1996 Vincenti F, Danovitch GM, Neylan JF, Steiner RW, Everson MP, Gaston RS
• Fibrosing cholestatic hepatitis in renal transplant recipients.
  Transplantation 1996 Lam PW, Wachs ME, Somberg KA, Vincenti F, Lake JR, Ferrell LD
• Histopathological concordance of paired renal allograft biopsy cores. Effect on the diagnosis and management of acute rejection.
  Transplantation 1995 Sorof JM, Vartanian RK, Olson JL, Tomlanovich SJ, Vincenti FG, Amend WJ
• Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection.
  Clinical transplantation 1995 Orloff SL, Stempel CA, Wright TL, Tomlanovich SJ, Amend WJ, Stock PG, Melzer JS, Vincenti F
• Phase II FK 506 multicenter concentration control study: one-year follow-up.
  Transplantation proceedings 1995 Laskow DA, Vincenti F, Neylan J, Mendez R, Matas A
• The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
  Transplantation 1995 Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F
• Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis.
  American journal of kidney diseases : the official journal of the National Kidney Foundation 1994 Artero ML, Sharma R, Savin VJ, Vincenti F
• Pentoxifylline reduces the first-dose reactions following OKT3.
  Transplantation proceedings 1993 Vincenti FG, Vasconcelos M, Birnbaum JL, Tomlanovich SJ, Amend WJ, Melzer JS, Snyder JP
• Nontransmission of hepatitis C from cadaver kidney donors to transplant recipients.
  Transplantation 1993 Vincenti F, Lake J, Wright T, Kuo G, Weber P, Stempel C
• Hepatitis C--its prevalence in end-stage renal failure patients and clinical course after kidney transplantation.
  Transplantation 1993 Stempel CA, Lake J, Kuo G, Vincenti F
• Recurrent focal glomerulosclerosis: natural history and response to therapy.
  The American journal of medicine 1992 Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F
• Cytokine and T cell receptor gene expression at the site of allograft rejection.
  Transplantation 1992 Krams SM, Falco DA, Villanueva JC, Rabkin J, Tomlanovich SJ, Vincenti F, Amend WJ, Melzer J, Garovoy MR, Roberts JP
• Hepatitis C virus in cadaver organ donors: prevalence and risk of transmission to transplant recipients.
  Transplantation proceedings 1991 Vincenti F, Weber P, Kuo G, Forsell J, Hunt S, Melzer J, Salvatierra O, Stempel C
• Effect of cyclosporine on the clinical course of HBsAg-positive renal transplant patients.
  Transplantation proceedings 1991 Stempel C, Lake J, Ferrell L, Tomlanovich S, Amend W, Salvatierra O, Vincenti F
• Improved results with combined donor-specific transfusion (DST) and sequential therapy protocol.
  Transplantation proceedings 1991 Salvatierra O, McVicar J, Melzer J, Amend W, Vincenti F, Tomlanovich S, Husing R, Rabkin J, Garovoy M
• Inability of cyclosporine to completely prevent the recurrence of focal glomerulosclerosis after kidney transplantation.
  Transplantation 1989 Vincenti F, Biava C, Tomlanovitch S, Amend WJ, Garovoy M, Melzer J, Feduska N, Salvatierra O
• Immunologic alterations induced by donor-specific transfusion.
  Transplantation proceedings 1989 Lockard-Marduel A, Gumbert M, Tomlanovich S, Amend W, Vincenti F, Schralla P, Melzer J, Feduska NJ, Salvatierra O, Garovoy MR
• Successful management of the highly sensitized renal allograft recipient.
  Transplantation proceedings 1989 Melzer JS, Husing R, Lou C, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Salvatierra O
• The incidence and impact of herpes simplex virus infections in the first month following renal transplantation.
  Transplantation proceedings 1989 Tomlanovich SJ, Sabatte-Caspillo J, Melzer J, Amend W, Vincenti F, Feduska N, Salvatierra O
• Cyclosporine provides better success rates for both higher- and lower-risk cadaveric kidney transplant recipients.
  Transplantation proceedings 1988 Feduska NJ, Melzer JS, Amend WJ, Vincenti F, Tomlanovich SJ, Garovoy M, Husing R, Salvatierra O
• How to improve results for second renal allografts.
  Transplantation proceedings 1988 Melzer JS, Husing RM, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Lou C, Salvatierra O
• Is cyclosporine effective in preventing recurrence of immune-mediated glomerular disease after renal transplantation?
  Transplantation proceedings 1988 Tomlanovich S, Vincenti F, Amend W, Biava C, Melzer J, Feduska N, Salvatierra O
• Posttransplant renal rejection: comparison of quantitative scintigraphy, US, and MR imaging.
  Radiology 1987 Hricak H, Terrier F, Marotti M, Engelstad BL, Filly RA, Vincenti F, Duca RM, Bretan PN, Higgins CB, Feduska N
• Donor-specific blood transfusions versus cyclosporine--the DST story.
  Transplantation proceedings 1987 Salvatierra O, Melzer J, Vincenti F, Amend WJ, Tomlanovich S, Potter D, Husing R, Garovoy M, Feduska NJ
• Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence?
  Transplantation proceedings 1987 Melzer JS, Husing RM, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Salvatierra O
• Observations relating to the incidence of the acquired immune deficiency syndrome and other possibly associated conditions in a large population of renal transplant recipients.
  Transplantation proceedings 1987 Feduska NJ, Perkins HA, Melzer J, Amend WJ, Vincenti F, Tomlanovich S, Garovoy M, Salvatierra O
• Sonography in the diagnosis of acute renal allograft rejection and cyclosporine nephrotoxicity.
  AJR. American journal of roentgenology 1987 Linkowski GD, Warvariv V, Filly RA, Vincenti F
• The beneficial effect of pretransplant blood transfusions in cyclosporine-treated cadaver renal allograft recipients.
  Transplantation 1987 Melzer JS, Husing RM, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Salvatierra O
• Renal allograft rejection: US evaluation.
  Radiology 1986 Hoddick W, Filly RA, Backman U, Callen PW, Vincenti F, Hricak H, Mahony BS, Amend W
• The clinical course of IgA-nephropathy and Henoch-Schönlein purpura following renal transplantation.
  Transplantation 1986 Bachman U, Biava C, Amend W, Feduska N, Melzer J, Salvatierra O, Vincenti F
• Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.
  Transplantation proceedings 1986 Feduska NJ, Melzer J, Amend WJ, Vincenti F, Tomlanovich S, Salvatierra O
• Is a "low" dose of prednisone better than a "high" dose at the time of renal transplantation?
  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 1986 Stabile C, Vincenti F, Garovoy M, Duca R, Melzer J, Feduska NJ, Salvatierra O, Amend WJ
• A seven-year experience with donor-specific blood transfusions. Results and considerations for maximum efficacy.
  Transplantation 1985 Salvatierra O, Melzer J, Potter D, Garovoy M, Vincenti F, Amend WJ, Husing R, Hopper S, Feduska NJ
• Pharmacokinetics of sulfisoxazole in renal transplant patients.
  Antimicrobial agents and chemotherapy 1985 Shermantine M, Gambertoglio J, Amend W, Vincenti F, Oie S
• Dramatic improvement in the success rate for renal transplants in diabetic recipients with donor-specific transfusions.
  Transplantation 1984 Feduska NJ, Melzer J, Amend W, Vincenti F, Duca R, Garovoy M, Hopper S, Salvatierra O
• Peptic ulcer disease in kidney transplant recipients.
  American journal of surgery 1984 Feduska NJ, Amend WJ, Vincenti F, Melzer JS, Duca R, Garovoy MR, Salvatierra O
• Parathyroid and bone response of the diabetic patient to uremia.
  Kidney international 1984 Vincenti F, Arnaud SB, Recker R, Genant H, Amend WJ, Feduska NJ, Salvatierra O
• Long-term renal function in kidney donors. Sustained compensatory hyperfiltration with no adverse effects.
  Transplantation 1983 Vincenti F, Amend WJ, Kaysen G, Feduska N, Birnbaum J, Duca R, Salvatierra O
• The role of blood transfusions in renal transplantation.
  The Urologic clinics of North America 1983 Salvatierra O, Vincenti F, Amend WJ, Garovoy MR, Potter D, Feduska NJ
• De novo and recurrent membranous glomerulopathy following kidney transplantation.
  Transplantation 1983 Berger BE, Vincenti F, Biava C, Amend WJ, Feduska N, Salvatierra O
• Furosemide assays and disposition in healthy volunteers and renal transplant patients.
  Federation proceedings 1983 Benet LZ, Smith DE, Lin ET, Vincenti F, Gambertoglio JG
• Urinary kallikrein excretion after renal transplantation: relationship to hypertension, graft source, and renal function.
  The American journal of medicine 1982 O'Connor DT, Barg AP, Amend W, Vincenti F
• Blood transfusions before and on the day of transplantation: effects on cadaver graft survival.
  Transplantation proceedings 1982 Feduska NJ, Amend WJ, Vincenti F, Duca R, Salvatierra O
• Update of the University of California at San Francisco experience with donor-specific blood transfusions.
  Transplantation proceedings 1982 Salvatierra O, Iwaki Y, Vincenti F, Amend W, Terasaki P, Garovoy M, Duca R, Hopper S, Feduska N
• Blood transfusions and kidney transplantation.
  Archives of internal medicine 1982 Vincenti F, Amend WJ, Feduska NJ, Salvatierra O
• Prednisone and prednisolone bioavailability in renal transplant patients.
  Kidney international 1982 Gambertoglio JG, Frey FJ, Holford NH, Birnbaum JL, Lizak PS, Vincenti F, Feduska NJ, Salvatierra O, Amend WJ
• Prognostic features of early renal transplant rejections.
  American journal of kidney diseases : the official journal of the National Kidney Foundation 1982 Amend WJ, Vincenti F, Duca R, Feduska NJ, Cochrum K, Potter D, Salvatierra O
• Septic arthritis following renal transplantation.
  Nephron 1982 Vincenti F, Amend WJ, Feduska NJ, Salvatierra O
• An alternative to cadaver kidney transplants for patients with insulin-dependent diabetes mellitus.
  Transplantation 1981 Feduska NJ, Vincenti F, Amend W, Iwaki Y, Opelz G, Terasaki P, Duca R, Hopper S, Salvatierra O
• Incidence, characteristics, and outcome of recipients sensitized after donor-specific blood transfusions.
  Transplantation 1981 Salvatierra O, Iwaki Y, Vincenti F, Amend W, Potter D, Opelz G, Terasaki P, Duca R, Hopper S, Feduska N
• Improved graft survival following donor-specific blood transfusions.
  Transplantation proceedings 1981 Cochrum K, Hanes D, Potter D, Perkins H, Amend W, Vincenti F, Iwaki Y, Opelz G, Terasaki P, Levin B, Sampson D, Feduska N, Salvatierra O
• Prevention of prednisone-induced negative nitrogen balance. Effect of dietary modification on urea generation rate in patients on hemodialysis receiving high-dose glucocorticoids.
  Annals of internal medicine 1981 Cogan MG, Sargent JA, Yarbrough SG, Vincenti F, Amend WJ
• 1,500 renal transplants at one center: evolution of a strategy for optimal success.
  American journal of surgery 1981 Salvatierra O, Amend W, Vincenti F, Potter D, Stoney R, Duca R, Feduska N
• Furosemide kinetics and dynamics after kidney transplant.
  Clinical pharmacology and therapeutics 1981 Smith DE, Gambertoglio JG, Vincenti F, Benet LZ
• Recurrent systemic lupus erythematosus involving renal allografts.
  Annals of internal medicine 1981 Amend WJ, Vincenti F, Feduska NJ, Salvatierra O, Johnston WH, Jackson J, Tilney N, Garovoy M, Burwell EL
• Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis.
  JAMA 1981 Vincenti F, Hattner R, Amend WJ, Feduska NJ, Duca RM, Salvatierra O
• Graft survival with high levels of cytotoxic antibodies.
  Transplantation proceedings 1981 Feduska NJ, Amend WJ, Vincenti F, Perkins HA, Opelz G, Terasaki PI, Iwaki Y, Duca R, Dodge D, Salvatierra O
• Improved graft survival with donor-specific transfusion pretreatment.
  Transplantation proceedings 1981 Cochrum K, Hanes D, Potter D, Perkins H, Amend W, Vincenti F, Iwaki Y, Opelz G, Terasaki P, Feduska N, Salvatierra O
• Pretreatment with donor-specific blood transfusions in related recipients with high MLC.
  Transplantation proceedings 1981 Salvatierra O, Amend W, Vincenti F, Potter D, Iwaki Y, Opelz G, Terasaki P, Duca R, Hanes D, Cochrum KC, Hopper S, Feduska NJ
• Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients.
  The Journal of clinical endocrinology and metabolism 1980 Gambertoglio JG, Vincenti F, Feduska NJ, Birnbaum J, Salvatierra O, Amend WJ
• Improved outcome following renal transplantation with reduction in the immunosuppression therapy for rejection episodes.
  The American journal of medicine 1980 Vincenti F, Amend W, Feduska NJ, Duca RM, Salvatierra O
• The role of hypertension in hemodialysis-associated atherosclerosis.
  The American journal of medicine 1980 Vincenti F, Amend WJ, Abele J, Feduska NJ, Salvatierra O
• Post-transplantation pyelonephritis: factors producing low patient and transplant morbidity.
  The Journal of urology 1980 Pearson JC, Amend WJ, Vincenti FG, Feduska NJ, Salvatierra O
• Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach.
  Annals of surgery 1980 Salvatierra O, Vincenti F, Amend W, Potter D, Iwaki Y, Opelz G, Terasaki P, Duca R, Cochrum K, Hanes D, Stoney RJ, Feduska NJ
• The organization of a successful donor-specific transfusion protocol in related recipients with high MLC.
  Proceedings of the Clinical Dialysis and Transplant Forum 1980 Hopper S, Feduska N, Vincenti F, Amend W, Salvatierra O
• Donor-specific blood transfusions in HLA-D-disparate one-haplotype-related allografts.
  Transplantation proceedings 1979 Cochrum KC, Hanes D, Potter D, Vincenti F, Amend W, Feduska N, Perkins H, Salvatierra O
• Results and significance of angiography in potential kidney donors.
  Radiology 1979 Spring DB, Salvatierra O, Palubinskas AJ, Amend WJ, Vincenti FG, Feduska NJ
• The transplanted kidney as a source of hepatitis B infection.
  Annals of internal medicine 1979 Wolf JL, Perkins HA, Schreeder MT, Vincenti F
• Analysis of costs and outcomes of renal transplantation at one center. Its implications.
  JAMA 1979 Salvatierra O, Feduska NJ, Vincenti F, Duca R, Potter D, Nolan J, Cochrum KC, Amend WJ
• Comparative study of albumin solution and cryoprecipitated plasma for renal preservation: a preliminary report.
  Transplantation proceedings 1979 Feduska NJ, Collins GM, Amend WJ, Vincenti F, Duca RM, Stieper KW, Mitchell JW, Cochrum KC, Salvatierra O
• HLA-D antigen disparity and HLA-DRw antibodies in intrafamilial renal allograft survival.
  Transplantation proceedings 1979 Cochrum K, Hanes D, Van Speybroeck J, Perkins H, Ferrone S, Indeveri F, Amend W, Vincenti F, Feduska N, Salvatierra O
• The influence of donor age on graft survival.
  American journal of surgery 1979 Speybroeck JV, Feduska N, Amend W, Vincenti F, Cochrum K, Salvatierra O
• Do blood transfusions enhance the possibility of a compatible transplant?
  Transplantation 1979 Feduska NJ, Vincenti F, Amend WJ, Duca R, Cochrum K, Salvatierra O
• Pretransplant cytotoxic antibodies do not segregate kidney transplant recipients into responder and non-responder groups.
  Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 1979 Vincenti F, Amend W, Feduska N, Duca R, Salvatierra O
• Immunologic factors determining survival of cadaver-kidney transplants. The effect of HLA serotyping, cytotoxic antibodies and blood transfusions on graft survival.
  The New England journal of medicine 1978 Vincenti F, Duca RM, Amend W, Perkins HA, Cochrum KC, Feduska NJ, Salvatierra O
• Leukocyte migration inhibitory factor (LIF) as an indicator of presensitization and allograft survival.
  Transplantation proceedings 1978 Cochrum KC, Haynes DM, Salvatierra O, Feduska NJ, Vincenti F, Van Speybroeck J
• The effect of hypothermic pulsatile perfusion on glomerular epithelial surface structures studied by scanning electron microscopy.
  Transactions - American Society for Artificial Internal Organs 1978 Vincenti F, Amend W, Feduska N, Maglio M, Axel L, Cochrum K, Salvatierra O
• Hepatitis-B reactivation after renal transplantation.
  Lancet (London, England) 1977 Denes AE, Berquist KR, Fields HA, Vincenti F
• Renal vein renin in hypertension. Diagnostic and therapeutic implications.
  Le Journal medical libanais. The Lebanese medical journal 1973 Vincenti F, Birbari A, Rizk G
• Tumorous hyperparathyroidism in hypophosphatemic vitamin D--resistant rickets.
  Le Journal medical libanais. The Lebanese medical journal 1973 Vincenti F, Hajjar ET, Salti IS